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Introduction
Cochlear implant (Ci) has developed into a commonly 
performed procedure for severe to profound deafness in 
patients who derive minimal benefit from conventional 
acoustic amplification. one of the most frequent com-
plications in the Ci procedure is inadvertent facial nerve 
stimulation (FnS). The electric current, passing through 
the electrode to the spiral ganglion cell, could spread to 
the nearby facial nerve causing symptoms ranging from 
simple awareness to severe facial spasm 1. Kelsall et al. 1 
proposed a grading system to document subjective facial 
nerve stimulation. This grading scale is based upon six 
degrees ranging from grade i corresponding to “no stimu-
lation” to grade Vi corresponding to “total stimulation: 
severe  gross  motion  of  total  facial  musculature  and/or 
severe pain” 1. Some scientific papers reported a variable 
FnS rate in Ci users raging between 1% and 14.9% 1-6. 
Cochlear malformations, otosclerosis, cochlear ossifica-
tion (post-meningitis, otosyphilis), temporal bone fracture 
and osteoporosis have been identified as predisposing fac-
tors to FnS 1-4 7 8. A lower rate of post-implant facial nerve 
stimulation is reported in children, probably due to a cer-
tain percentage of misdiagnosed cases 9. The FnS onset 
can be immediate or delayed. it usually occurs within the 
first year after implantation but it could develop up to 10 
years later.
Several hypotheses have been advanced to explain the 
pathogenesis of FnS following Ci. First the close prox-
imity of the facial nerve to the lateral wall of the cochlea 
(in the superior segment of the basal turn) could explain 
why the mid-array (corresponding to electrodes 16-17 in 
22 electrodes straight arrays and to electrodes 16 to 18 
in 22 electrodes perimodiolar arrays) is most frequently 
involved in FnS 1 8. other factors responsible for FnS 
could be a low impedance pathway at the modiolar base, 
high stimulation levels necessary to stimulate hypoplasic 
acoustic nerves or malfunctioning electrodes. Finally, in 
patients with otosclerosis, the new soft and remodelled 
bone has a lower impedance and this could be responsible 
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Post-implantation facial nerve stimulation is one of the best known and most frequent complications of the cochlear implant procedure. 
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La stimolazione del nervo facciale è una delle complicanze più comuni e meglio conosciute della procedura di impianto cocleare. Alcu-
ne condizioni come l’otosclerosi, le malformazioni cocleari ma anche gli elevati livelli di stimolazione, che possono essere necessari in 
pazienti con lunga deprivazione uditiva, sottopongono i pazienti ad un maggior rischio di sviluppare la stimolazione del nervo facciale. 
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al 2007 presso la Clinica ORL dell’Università di Pisa) che hanno sviluppato la stimolazione del nervo facciale.
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for the high rate of FnS in these patients 10. Some Au-
thors also hypothesized that the array of electrodes could 
erode the bony layer between the scala tympani and facial 
nerve 8. Various methods have been proposed to eliminate 
FnS, such as changing the programming strategy and/or 
stimulation mode, turning off some electrodes, reducing 
the C-levels under FnS thresholds and also a re-implanta-
tion with a new device.
The aim of this study was to analyse the clinical features 
of patients who developed post-implantation FnS, in a 
group of 119 patients consecutively implanted at the EnT 
Clinic of the university of Pisa.
Material and methods
A retrospective chart review was used for 119 patients, 
60 males (50.4%) and 59 females (49.6%), who had been 
consecutively implanted at the EnT Clinic of the uni-
versity of Pisa between January 1999 and January 2007. 
only those patients implanted with the nucleus 24 Ci, 
manufactured  by  Cochlear  Corporation  (Sydney,  Aus-
tralia) were included in the study. overall, 99 patients 
(83.2%) received the nucleus Contour or Contour Ad-
vance  electrode  arrays,  19  (16%)  the  straight  nucleus 
electrode arrays and one patient (0.8%) received a double 
array. of these patients, 63 were adults (age ≥ 18 years) 
and 56 were children. in the group of adult patients, 25/63 
(39.7%) were pre-lingually deafened, and 38/63 (60.3%) 
were post-lingually deafened. All the patients were oper-
ated upon by the same surgical team and the final inser-
tion of the Ci was performed by the same senior surgeon, 
in all the patients. in all cases, the array of electrodes was 
fully inserted. A post-operative X-ray of the skull was 
performed to confirm correct placement of the Ci. FnS 
was defined as the presence of any facial movement at or 
below the maximum comfortable level (C-level) on one 
or more electrodes. FnS was managed by modifying Ci 
fitting parameters, as follows: decreasing stimulation lev-
els, switching off the offending electrodes and changing 
stimulation modes and/or the coding strategies, if neces-
sary. The duration of follow-up is > 24 months for all the 
patients. A retrospective analysis was performed on the 
clinical  charts,  programming  records,  surgical  reports, 
and imaging reports.
Results
of the 119 patients reviewed, 11 (9.2%) patients were 
identified with FnS, mean age 41 years and 5 months 
(range  27  months  -  67  years);  of  these,  7/11  patients 
(63.6%) were adult and 4/11 (36.4%) were children. FnS 
occurred in 11% of the adult Ci recipients and in 7.1% 
of the paediatric recipients. The onset of FnS was imme-
diate in 4/11 patients (36.4%), within the first year after 
activation in one patient (9%), and 1 year or more after 
activation in 6/11 patients (54.6%). in the group of pa-
tients with FnS, 4/11 had some inner ear and cochlear 
nerve anomalies: 1 child had a malformed cochlea with 
hypoplasia of the cochlear nerve, 2 adult patients had a 
cochlear otosclerosis and one adult patient had a cochlear 
ossification due to meningitis. Among the remaining 7 pa-
tients with FnS, one adult patient had a Central nervous 
System Superficial Siderosis (CnSSS), 2 children had a 
genetic deafness with a homozygous mutation of the gene 
codifying for Connexin 26, 3 adult patients had an idi-
opathic pre-lingual deafness, and one child had a history 
of high grade prematurity (Fig. 1). no cases of extrusion, 
migration or failure of the electrodes were observed in 
any of the patients.
in all the patients, FnS was successfully eliminated and 
none of the patients stopped using the implant due to FnS. 
Explantation or reintervention was not necessary in any of 
these cases. in 6/11 patients, FnS was eliminated with 
success, minimally reducing stimulation levels (C-level) 
and without any significant deterioration of the outcome.
in the remaining 5 patients, exclusion of the stimulating 
electrodes and an important reduction in stimulation lev-
els were necessary, leading to a deterioration in hearing: 
in  two  patients,  the  results  remained  reasonably  good, 
while in 3 cases they became unsatisfactory. As far as 
concerns the three latter patients (one with otosclerosis, 
one with CnSSS and one with malformed cochlea), one 
is able only to discriminate words in closed set (70% of 
identification of words in closed set), one patient is only 
able to detect sounds, while the patient with malformed 
cochlea has a very low hearing sensation.
Discussion
FnS has long been recognized as a complication of the 
Ci procedure. in the last 20 years, several reports regard-
ing FnS have been published. The reported rate of FnS 
with multi-channel cochlear implants varies considerably, 
ranging from 0.9% to 14.6% as reported in Table i. The 
incidence of FnS, in our group of Ci recipients, is 9.2% 
and is similar to that reported in other reports in the lit-
erature. in paediatric Ci recipients, the reported FnS rate 
is generally slightly lower in comparison to that in adults 
(3% reported by Kempf et al. 4 and 0.9% reported by hoff-
Fig. 1. Aetiology of deafness in the present series.Facial nerve stimulation after cochlear implantation
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man and Cohen 11) and this could be due to the difficulty 
in diagnosing mild FnS. in this regard, Cushing et al. 9 re-
cently supposed that children may not be able to comment 
on the presence of facial twitching and that it is possible 
that, inspecting facial movements, not all facial stimula-
tions are identified. in the above-mentioned publication. 
the Authors reported a very high incidence of FnS (59% 
in a prospective group and 34% in a retrospective group) 
defined as electromyographic responses of the facial mus-
culature. in our series, FnS, observed by inspecting facial 
movements, occurred in 7.1% of the implanted children. 
There were no significant sex differences, as reported in 
literature 12. The onset of FnS is often variable as shown 
in Table i. only a few papers have reported the time be-
tween Ci activation and the onset of FnS 1 2 8 12-14. review-
ing these papers, of the 81 patients with FnS, in which the 
onset was timed, 32 had an immediate onset and 49 had 
a delayed onset. Thus delayed onset of FnS is not as rare 
as previously hypothesized 15. with regard to delayed FnS 
pathogenesis in Ci users, some Authors hypothesized that 
the delayed onset could be due to formation of adhesions 
following an inflammatory process within the temporal 
bone 14. others suggest a change in current pathway or 
tissue impedance or in facial nerve sensitivity 12. Bigelow 
et al. 8 hypothesized that the array of electrodes could 
erode the thin bony layer between the scala tympani and 
the facial nerve. in our series, 4/11 (36.4%) patients had 
an immediate onset of FnS and 7/11 (63.6%) had a de-
layed onset. An interesting finding was that 6/11 (54.1%) 
patients developed FnS one year after Ci activation or 
much later. This delay, in some cases, could be related to 
an increase in stimulation levels over time.
There  are  several  cochlear  disorders  (otosclerosis,  co-
chlear malformations, cochlear ossification, closed head 
injury and temporal bone fractures) that have been associ-
ated with a higher incidence of FnS 1-4 7 8.
in the study outlined herewith, 4/11 patients with FnS 
presented cochlear anomalies that probably contributed to 
the stimulation. There were 2 patients with otosclerosis, 
one patient with labyrinthitis ossificans due to meningitis 
and one patient with inner ear malformations and bilateral 
hypoplasia of the cochlear nerve.
with regard to otosclerosis, 6 patients out of 119 (5%) 
from our series were otosclerotic and two patients in this 
group had FnS. one of the two patients was implanted 
with a perimodiolar electrode and developed an immediate 
FnS. The other patient was implanted with a straight elec-
trode and presented a delayed and progressive FnS. The 
incidence of FnS, in our series of implanted otosclerotic 
patients, is 33% (2 out of 6), while in previous publica-
tions 1 3 6 7 16 an incidence between 17 and 75% is reported. 
This higher incidence is thought 10-17 to be due to extra-
cochlear current spread due to reduced electric resistance 
exerted by the otospongiotic labyrinthine bone. Another 
hypothesis is that FnS could result from the decrease in 
distance from the electrode’s array to the facial nerve due 
to loss of bone and cavity formation 18. FnS, in otosclerotic 
patients, is reported 7-16 to be more frequent in those patients 
Table I. Reported rate of FNS with multi-channel cochlear implants.
Investigators Year Incidence Onset
Cohen et al. (5) 1988 4/459 (0.9%) Not reported
Niparko et al. (2) 1991 12/82 (14.6%) 2/12 (16.7%)  immediate
4/12 (33.3%) < 3 months
6/12 (50%)  3 - 18 months
Bachor et al. (13) 1993 3/53 (5.6%) Not reported
Shea and Domico (14) 1994 8/109 (7.3%) 6/8 (75%) immediate
2/8 (25%) < 1 year
Muckle et al. (3) 1994 4/38 (10.5%) Not clearly reported
Hoffman and Cohen (11) 1995 101/4969 (2%) Not reported
Kelsall et al. (1) 1997 14/200 (7%) 7/14 (50%) immediate
7/14 (50%) < 1 year
Bigelow et al. (8) 1998 8/58 (13.8%) 3/8 (37.5%) immediate
4/8 (50%) < 1 year
1/8 (12.5%) >1 year
Kempf et al. (4) 1999 38/667 (5.7%) Not reported
Broomfield et al. (30) 2000 20/163 (12.3%) Not reported
Rayner et al. (6) 2003 12/147 (8.1%) Not reported
Smullen et al. (12) 2005 39/600 (6.5%) 14/39 (35.9%) immediate
19/39(48.7%) <1 year
6/39 (15.4%) >1 year
Ahn et al. (25) 2009 23/394 (5.8%) Not reportedS. Berrettini et al.
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with the most severe confluent disease (grade iii) revealed 
in CT scans. Thus CT scans could be helpful in predict-
ing FnS and may be decisive in establishing the side of 
implantation 7. The two patients with otosclerosis and FnS 
after Ci, collected from our series, had a grade iii disease, 
confirmed radiologically; indeed, the patients had a diffuse 
confluent retro-fenestral involvement of the otic capsule 
also with fenestral involvement (Fig. 2).
The  anomalous  cochleo-vestibular  anatomy,  as  men-
tioned above, has been associated with a higher incidence 
of FnS. Papsin 19 reported a high incidence of FnS, at 
normal stimulation levels, in patients with anomalous co-
chlear anatomy. The Author also reported a higher inci-
dence, in these patients, of an anomalous course of the fa-
cial nerve 19. Cushing et al. 9 reported 8 children with FnS 
out of 10 implanted with a malformed cochlea (80%). The 
percentage of FnS in anomalous cochlea, in our series, 
is lower than in previous reports. overall, 7/119 patients 
(5.8%) from our series had some cochlear anomalies (one 
had a common cavity, 2 a mondini anomaly, 3 an enlarged 
vestibular aqueduct and one a Viii nerve hypoplasia), but 
only one patient developed FnS. This child presented a 
malformed temporal bone with bilateral agenesis of the 
lateral semicircular canal, no identifiable bone layer be-
tween the basal and second turn of the cochlea and a nar-
rowed internal auditory meatus with hypoplasic cochlear 
nerve bilaterally (Fig. 3). The very low number of coch-
lear nerve fibres in this patient led us to increase stimula-
tion levels. unfortunately, a facial twitching appeared and 
it was necessary to switch off the offending electrodes and 
reduce the stimulation levels of the remaining electrodes. 
This was not sufficient to reach an adequate hearing sen-
sation and, with the Ci, the child has only a low hearing 
sensation, not sufficient for speech discrimination.
A significant percentage of the patients reported herein, 
i.e.,  3  out  of  11  patients,  were  prelingually  deafened 
adults. Prelingually deafened adult patients are generally 
used to very high stimulations, mostly in the low frequen-
cies range. This is probably the reason why they frequent-
ly ask for high stimulation levels with Ci. moreover, some 
of them may have a hypoplasic cochlear nerve for the long 
auditory deprivation, requiring high stimulation levels to 
gain an adequate hearing sensation with the Ci. This could 
explain why, in our series, a relatively high percentage of 
patients developed a progressive FnS, one year or more 
after implantation.
one patient in this series was affected by CnSSS. This 
disorder is characterized by intracellular and extracellular 
deposits of hemosiderin in the leptomeninges, subpial tis-
sue, spinal cord, and cranial nerves 20. CnSSS symptoms 
are progressive hearing loss, ataxia, pyramidal signs and 
dementia 20. Ci would appear to play a possible role in 
the treatment of patients affected by CnSSS 20-23. A more 
recent report 24 described two patients affected by CnSSS 
who gained no benefit from the Ci procedure. They hy-
pothesized that poor results could be due to an ongoing 
neural deterioration of the retrocochlear pathways. This is 
probably what occurred in the patient reported here, who 
needed high stimulation levels (to reach an adequate hear-
ing sensation) due to the deterioration of the retrocochlear 
pathways determining FnS.
Some Authors 7 25-27 described a higher incidence of FnS in 
patients with anomalous cochleas implanted with straight 
electrodes rather than patients implanted with perimodi-
olar electrodes. Perimodiolar electrodes with contacts fac-
ing towards the modiolus have a less current flow towards 
the outer wall of the cochlea 26. in the literature, no differ-
ence in the incidence of FnS, between perimodiolar and 
straight electrodes, in patients with normal cochleas, has 
been reported 7 12 25. Ahn et al. 25 reported a difference in the 
incidence of FnS between the devices with perimodiolar 
electrodes; it was significantly lower in patients with the 
nucleus Contour Advance Soft Tip than in patients with 
the nucleus Contour. This could be due to the design of 
this array studied in order to preserve the delicate struc-
ture and minimize lateral wall forces on the cochlea dur-
ing the insertion. in our series, only one patient out of 19 
implanted with straight electrode arrays developed FnS. 
This patient was the only one affected by otosclerosis in 
the group of 19 implanted with this type of array.
Fig. 2. Pre-operative CT shows the confluent retro-fenestral involvement of 
bilateral otic capsule.
Fig. 3. a) CT shows the anomalous anatomy of the patient. There is bilateral 
agenesis of lateral semicircular canal, no identifiable bone layer between ba-
sal and second turn of the cochlea and a narrowed internal auditory canal; 
b) same anomalies at MRI 3D reconstruction.Facial nerve stimulation after cochlear implantation
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FnS,  with  deterioration  of  hearing,  can  also  be  the 
initial manifestation of a ‘soft failure’ of the device. 
For that reason, it has been included in the check-list 
of  non-auditory  symptoms  suggesting  the  “soft  fail-
ure” of the device by some Authors 28. Various methods 
have been suggested by the Authors to eliminate FnS. 
Changing  mapping  strategies  and  stimulation  modes, 
lowering  the  current  amplitude,  increasing  the  pulse 
width have been proposed as possible solutions 1 29. if 
these mAP modifications are not effective, as described 
by Shea and domico 14, it might be necessary to switch 
off the offending electrodes. This technique could lead 
to a significant deterioration in speech perception 26. in 
other cases of refractory FnS, a revision surgery has 
been  performed  26  29.  in  our  series,  in  6/11  patients, 
FnS was eliminated with success, minimally reducing 
stimulation levels (C-level) without any deterioration in 
speech perception. in the remaining 5 patients, it was 
necessary both to switch off the stimulating electrodes 
and to reduce the stimulation levels. in these patients, a 
deterioration in the hearing outcome was observed: in 
2 patients, the results remained good, while in 3 they 
became unsatisfactory.
Conclusions
FnS is one of the well-known and most frequent minor 
complications of the Ci procedure. it can produce sig-
nificant discomfort, in some cases affecting the outcome 
and limiting the use of an implant. FnS can occur im-
mediately upon Ci activation but more frequently can 
be delayed, as confirmed by our results. Some condi-
tions (otosclerosis, cochlear malformation, trauma, etc.) 
predispose patients to the development of post-implant 
FnS: these have to be taken into account for proper pre-
operative counselling and surgical planning, including 
the choice of the device. The management of FnS re-
quires  familiarity  with  programming  techniques  and, 
in some cases, surgical explantation or re-implantation. 
generally, FnS can be resolved minimally by modifying 
the mAPs, but this can lead to a reduction in hearing 
outcome in some patients
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